SOX2 expression is correlated with the prognosis of some human cancers such as non-small cell lung cancer and cervical cancer with better prognosis [20, 21] and breast cancer and gastric cancer with worse prognosis [18, 19]. This evidence concerns the gene SOX2 and gastric cancer.